Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment

John Lin; Jing Ouyang; Xiao-Rong Peng; Stéphane Isnard; Brandon Fombuena; Jean-Pierre Routy; Yao-Kai Chen

doi:10.1097/CM9.0000000000000816

Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment

Chin Med J (Engl). 2020 Jun 5;133(11):1350-1352. doi: 10.1097/CM9.0000000000000816.

Authors

John Lin^{1

2}, Jing Ouyang³, Xiao-Rong Peng^{1

2

4}, Stéphane Isnard^{1

2}, Brandon Fombuena^{1

2

5}, Jean-Pierre Routy^{1

2

6}, Yao-Kai Chen³

Affiliations

¹ Infectious Diseases and Immunity in Global Health Program, Research Institute, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
² Chronic Viral Illness Service, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.
³ Division of Infectious Diseases, Chongqing Public Health Medical Center, Chongqing 400036, China.
⁴ State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310000, China.
⁵ Department of Microbiology and Immunology, McGill University, Montréal, QC H3A 0G4, Canada.
⁶ Division of Hematology, McGill University Health Centre, Montréal, QC H4A 3J1, Canada.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / drug therapy*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
SARS-CoV-2

Substances

Antiviral Agents